INCYTE CORP 4

Steven H. Stein, CMO & Head of Late-Stage Development of Incyte Corp (INCY), sold 28,237 shares of common stock and had 24,918 shares withheld for taxes over July 14–15, 2026.

On July 14, 2026, Incyte Corporation CMO & Head of Late-Stage Development Steven H. Stein had 21,830 shares of common stock withheld by the issuer at an implied price of $114.88 per share (approximately $2.51 million) to satisfy tax obligations related to previously reported RSU and performance share settlements, reducing his direct holdings to 54,320 shares. On July 15, 2026, he conducted an open market sale of 28,237 shares of common stock at an average price of $113.05 per share for proceeds of roughly $3.19 million, followed the same day by an additional 3,088 shares withheld for taxes at $115.09 per share (about $0.36 million), leaving him with 22,995 directly owned shares, which are also noted as including 19,540 unvested RSUs and earned performance shares. The bulk of the share movements are driven by routine tax-withholding on equity compensation, but the sizable discretionary sale adds meaningful net selling activity by a senior executive.

Filing Facts

CIK

879169

Ticker

INCY

Form

4

Source Type

fda

Accession

0001673776-26-000017

Alert Tier

7